Detect And Visualize Lesions With Abnormal Vascularity With Mri — Patent Landscape
1
Approved drugs
27
Active US patents
39/100
Avg vulnerability
—
Annual revenue covered
Originators in Detect And Visualize Lesions With Abnormal Vascularity With Mri
Cliff calendar — next 15 years
7
28
7
39
13
40
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Elucirem
GADOPICLENOL
|
Guerbet | 27 | 39 | — | 2028-09-19 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 12064487 | Elucirem | method of use | 75 | 2040-01-17 |
| 11590246 | Elucirem | formulation | 50 | 2040-01-17 |
| 11590246 | Elucirem | formulation | 50 | 2040-01-17 |
| 11590246 | Elucirem | formulation | 50 | 2040-01-17 |
| 11590246 | Elucirem | formulation | 50 | 2040-01-17 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 10973934 | Elucirem | composition of matter | 12 | 2039-08-06 |
| 8114863 | Elucirem | composition of matter | 25 | 2028-09-19 |
| 8114863 | Elucirem | composition of matter | 25 | 2028-09-19 |
| 8114863 | Elucirem | composition of matter | 25 | 2028-09-19 |
Related
- Detect And Visualize Lesions With Abnormal Vascularity With Mri — full disease profile
- AI Patent Landscape Report — type "detect and visualize lesions with abnormal vascularity with mri" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner